Correction to: Scientific Reports 10.1038/s41598-019-57192-2, published online 17 January 2020
This Article contains errors where n values were omitted from some of the Figure and Table legends.
In the legend of Figure 1,
“(b) Effect of HST (1, 10, 100 μg/mL) on the scratch-induced migration of HOKs over time. (c) Extent of the scratch-induced migration of HOKs treated with HST (1, 10, 100 μg/mL) for 72 h calculated as the ratio of vehicle [confluence of HOKs (%) in wound area treated with HST/that treated with vehicle]. (d) Cell viability in HOKs treated with vehicle or HST (1, 10, 100 μg/mL) for 72 h. Data are expressed as the ratio of vehicle at 72 h.”
should read:
“(b) Effects of HST (1, 10, 100 µg/mL) on the scratch-induced migration of HOKs over time (n = 12–13). (c) Extent of the scratch-induced migration of HOKs treated with HST (1, 10, 100 µg/mL) for 72 h calculated as the ratio of vehicle [confluence of HOKs (%) in wound area treated with HST/ that treated with vehicle (n = 12–13). (d) Cell viability in HOKs treated with vehicle or HST (1, 10, 100 µg/mL) for 72 h (n = 14). Data are expressed as the ratio of vehicle at 72 h.”
In the legend of Figure 2,
“HOKs were treated with 1, 10, or 30 μg/mL of Pinellia tuber (a), Scutellaria root (b), processed ginger (c), Glycyrrhiza (d), jujube (e), ginseng (f), or Coptis rhizome (g).”
should read:
“HOKs were treated with 1, 10 or 30 µg/mL of pinellia tuber (a), Scutellaria root (b), processed ginger (c), Glycyrrhiza (d), jujube (e), ginseng (f), and Coptis rhizome (g) (n = 15–18)."
In the legend of Table 1,
“HOKs were treated with various ingredients of Scutellaria root (baicalin, baicalein, and wogonin), processed ginger ([6]-shogaol, [8]-shogaol, [10]-shogaol, [6]-gingerol, [8]-gingerol, and [10]-gingerol), and Gglycyrrhiza (glycyrrhizin, liquiritin, isoliquiritin, liquiritin apioside, and isoliquiritigenin) for 72 h. Data are expressed as the ratio of vehicle at 72 h.”
should read:
“HOKs were treated with various ingredients of scutellaria root (baicalin, baicalein and wogonin), processed ginger ([6]-shogaol, [8]-shogaol, [10]-shogaol, [6]-gingerol, [8]-gingerol and [10]-gingerol) and Glycyrrhiza (glycyrrhizin, Liquiritin, Isoliquiritin, Liquiritin apioside, and Isoliquiritigenin) for 72 h (n = 11–20). Data are expressed as the ratio of vehicle at 72 h.”
In the legend of Figure 4,
“HOKs were co-treated with HST (100 μg/mL) and an ERK inhibitor U0126 (10 μM, a), JNK inhibitor II (1 μM, b), p38 inhibitor SB202190 (10 μM, c), or a CXCR4 inhibitor BDPA-Zn (3 μM, d).”
should read:
“HOKs were co-treated with HST (100 µg/mL) and an ERK inhibitor U0126 (10 µM, a), a JNK inhibitor II (1 µM, b), a p38 inhibitor SB202190 (10 µM, c) or a CXCR4 inhibitor BDPA-Zn (3 µM, d) (n = 18–51)."
In the legend of Figure 6,
“HSC-4 (a), SCC-25 (b), DLD-1 (c), and MKN-45 (d) cell lines were treated with HST for 72 h, then cell growth was measured using Cell Counting Kit-8. HSC-4 (e) and SCC-25 (f) cells were treated with HST (1, 10, and 100 μg/mL) for 72 h, then the area occupied by cancer cells on the scratched area was quantified using IncyCyte scratch wound cell migration software (ESSEN BioScience).”
should read:
“HSC-4 (a), SCC-25 (b), DLD-1 (c) and MKN-45 (d) cell lines were treated with HST for 72 h, then cell growth were measured using Cell Counting Kit-8 (n = 9). HSC-4 (e, n = 8–16) and SCC-25 (f, n = 3–7) cells were treated with HST (1, 10, 100 µg/mL) for 72 h, then the area occupied by cancer cells on the scratched area were quantified using IncuCyte scratch wound cell migration software (ESSEN BioScience).”